Results 211 to 220 of about 630,004 (299)
Post-translational modifications in ovarian cancer: implications for immunotherapy: a mini-review. [PDF]
Sun L, Guo YF, Duan CC, Chen C, Xiao L.
europepmc +1 more source
Core Fucosylation Represses SMURF1‐Dependent Degradation of CD47 to Promote Tumor Immune Evasion
FUT8‐mediated core fucosylation of CD47 at N111 blocks SMURF1 binding and reduces CD47 ubiquitination and degradation. Blocking N111 glycosylation reduces CD47 expression and promotes macrophage phagocytosis of tumor cells. Furthermore, ablating CD47 core fucosylation boosts CD103+ dendritic cells (DCs) infiltration, increases natural killer (NK) cell ...
Yuting Cao +8 more
wiley +1 more source
Epstein-Barr virus functional RNAs as part of its immune evasion strategy: a role for EBER1? [PDF]
Farrell PJ.
europepmc +1 more source
The Ethics of Tax Evasion: A Comparative Study of Guangzhou (Southern China) and Macau Opinion
Robert W. McGee, Carlos Noronha
openalex +1 more source
Multiomics integration analysis reveals the “cystic fluid–tumor cell” metabolic coupling that mediates active choline/ethanolamine uptake of tumor cells from cystic fluid and PC/PE synthesis pathways reprogramming that mediating autophagy pathway activation within ACP. ABSTRACT Adamantinomatous craniopharyngioma (ACP), a benign yet highly recurrent and
Dongting Chen +9 more
wiley +1 more source
ZNF184-mediated transcriptional activation of SAE1 drives the cell cycle entry and immune evasion in non-small cell lung cancer. [PDF]
Shi F, Zhang L, Wang C, Meng Q.
europepmc +1 more source
In non‐MASH‐HCC, L‐carnitine promotes tumor progression primarily through its classical role in enhancing fatty acid oxidation (FAO). However, in MASH‐HCC, where FAO is markedly suppressed, L‐carnitine shifts from this canonical function to serve instead as an intracellular acetyl group buffer.
Chuqi Xia +11 more
wiley +1 more source
Mitochondrial transfer: a Janus-faced force in health and disease. [PDF]
Hu Y, Zhou W, Chen L.
europepmc +1 more source

